Denmark Sepsis Diagnostics Market Size & Outlook

The sepsis diagnostics market in Denmark is expected to reach a projected revenue of US$ 4.4 million by 2030. A compound annual growth rate of 6.6% is expected of Denmark sepsis diagnostics market from 2023 to 2030.
Revenue, 2022 (US$M)
$2.6
Forecast, 2030 (US$M)
$4.4
CAGR, 2023 - 2030
6.8%
Report Coverage
Denmark

Denmark sepsis diagnostics market highlights

  • The Denmark sepsis diagnostics market generated a revenue of USD 2.6 million in 2022 and is expected to reach USD 4.4 million by 2030.
  • The Denmark market is expected to grow at a CAGR of 6.6% from 2023 to 2030.
  • In terms of segment, blood culture media was the largest revenue generating product in 2022.
  • Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.


Sepsis diagnostics market data book summary

Market revenue in 2022USD 2.6 million
Market revenue in 2030USD 4.4 million
Growth rate6.6% (CAGR from 2022 to 2030)
Largest segmentBlood culture media
Fastest growing segmentAssay Kits & Reagents
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Blood Culture Media, Assay Kits & Reagents, Software
Key market players worldwideBD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress


Other key industry trends

  • In terms of revenue, Denmark accounted for 0.3% of the global sepsis diagnostics market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 82.5 million by 2030.

Blood culture media was the largest segment with a revenue share of 38.46% in 2022. Horizon Databook has segmented the Denmark sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.


A study published by the National Library of Medicine in April 2024 estimated the incidence of community-acquired sepsis to be 731 cases per 100,000 person-years at risk in Denmark, based on an analysis of symptoms and clinical notes recorded upon hospital admission.

This estimation highlights the significant prevalence of community-acquired sepsis and highlights the importance of early detection & intervention to effectively manage this serious condition. Sepsis is the third leading cause of death in Denmark.

Several research groups and companies are making considerable progress in developing new diagnostic technologies for sepsis. For instance, in August 2019, an article published in Europe PMC stated that researchers from the University Hospital of Copenhagen found that sepsis-related acute liver damage is a common and serious condition in critically ill individuals and can be detected with the help of biomarkers.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Sepsis Diagnostics Market Companies

Name Profile # Employees HQ Website

Denmark sepsis diagnostics market size, by product, 2018-2030 (US$M)

Denmark Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)

Denmark sepsis diagnostics market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more